Advances in AI drug discovery and digital transformation are forcing the pharmaceutical industry to undergo fundamental structural reforms across the entire value chain, from research and development to post-marketing. In this time of change, we have the expertise and knowledge to lead change to success with optimal approaches, from research and development to medical care, sales and marketing, etc.
Advances in AI drug discovery and digitalization, as well as drug pricing reforms, global regulations, and increasingly complex supply chains, are forcing the pharmaceutical industry to undergo structural transformation across the entire value chain, from research and development to post-marketing. These environmental changes are manifesting as unique challenges for each function, with R&D requiring the use of external assets and accelerated PoC, medical affairs requiring evidence generation and digital utilization, and sales and marketing requiring omnichannel support and advanced SFE. It is essential for companies to optimize each function, assuming transformation across the entire value chain.
In this environment, what is important is not just strategy planning, but support that is rooted in the field and includes the ability to execute. INTLOOP Strategy’s Life Sciences Practice combines strategic consulting expertise with practical experience at pharmaceutical companies to provide “consistent support from conception to execution.”
What sets us apart is the concept development capabilities of consultants from major firms, as well as the flexible use of a network of over 52,000 freelance experts. By incorporating practitioners with intimate knowledge of the field into projects, we achieve “transformation that leads to results” that goes beyond armchair theory.
We have particular strengths in commercial areas such as marketing strategies, new drug launches, SFE/targeting refinement, and omni-channel initiatives, and have a proven track record in the oncology field, including hematological cancers. We are also expanding our support in a wide range of areas, including medical affairs, regulatory affairs/quality assurance, manufacturing, and IT/DX, providing multifaceted support for each company’s growth strategies and organizational transformation.
This combination of strategic knowledge, practical experience, and a network of specialized talent provides us with the agility and on-site experience that large firms lack, enabling us to produce results in a short period of time.
By supporting both the strategy and execution aspects, we help our clients to steadily promote realistic initiatives in line with their company’s strategies and achieve effective results.
